Severity assessment of lower respiratory tract infection in elderly patients in primary care.

BACKGROUND Simple markers for evaluating the severity of lower respiratory tract infections (LRTI) in primary care are lacking. It is of value to examine whether the information available to the primary care physician during a patient's initial visit can be used to assess the severity of LRTI. METHODS The associations between different baseline variables and outcomes (survival within or more than 30 days) were investigated prospectively in a series of 950 home-living patients 65 years or older with severe LRTI that their primary care physicians suspected to be pneumonia. RESULTS Twenty-one men and 17 women died (4.1%) within 30 days. According to univariate analysis, the following parameters differed (P < .01) between the fatalities and survivors: acute aggravation of a coexisting illness, age, respiratory rate, white blood cell count, and C-reactive protein (CRP) level. According to Cox forward stepwise regression analysis (P = .01 for entry and.05 for removal), acute aggravation of a concurrent illness, respiratory rate (> or = 25/min), and CRP concentration (> or = 100 mg/L) were independently associated with death. The mortality rate was 2.2% if the patients had none or only 1 of the independent risk factors and 20% if they had all 3 risk factors. CONCLUSIONS Preceding aggravation of a concurrent illness and respiratory rate of 25/min or higher, together with an elevated serum CRP level (> or = 100 mg/L), can be used as simple markers for identifying patients with the highest risk for LRTI and improve management decisions among elderly people in primary care.

[1]  Inger,et al.  A prediction rule to identify low-risk patients with community-acquired pneumonia. , 1997, The New England journal of medicine.

[2]  N. Dean,et al.  Use of prognostic scoring and outcome assessment tools in the admission decision for community-acquired pneumonia. , 1999, Clinics in chest medicine.

[3]  S. Ewig,et al.  Comparative validation of prognostic rules for community-acquired pneumonia in an elderly population. , 1999, The European respiratory journal.

[4]  M. Leinonen,et al.  Incremental effectiveness of pneumococcal vaccine on simultaneously administered influenza vaccine in preventing pneumonia and pneumococcal pneumonia among persons aged 65 years or older. , 1999, Vaccine.

[5]  J. Macfarlane Lower respiratory tract infection and pneumonia in the community. , 1999, Seminars in respiratory infections.

[6]  D. Thévenin,et al.  Community‐Acquired Pneumonia in the Intensive Care Unit: Epidemiological and Prognosis Data in Older People , 1999, Journal of the American Geriatrics Society.

[7]  I. Kushner,et al.  Acute-phase proteins and other systemic responses to inflammation. , 1999, The New England journal of medicine.

[8]  C. VandenBussche,et al.  Epidemiological features and prognosis of severe community-acquired pneumococcal pneumonia , 1999, Intensive Care Medicine.

[9]  Y. Chen,et al.  A prognostic rule for elderly patients admitted with community-acquired pneumonia. , 1999, The American journal of medicine.

[10]  Sheldon P Stone,et al.  Community-acquired pneumonia , 1998, The Lancet.

[11]  J. Bartlett,et al.  GUIDELINES FROM THE INFECTIOUS DISEASES SOCIETY OF AMERICA Community-Acquired Pneumonia in Adults: Guidelines for Management , 1998 .

[12]  M. Kolczak,et al.  Incidence of Community-Acquired Pneumonia Requiring Hospitalization Results of a Population-Based Active Surveillance Study in Ohio , 1997 .

[13]  J. Guest,et al.  Community-acquired pneumonia: the annual cost to the National Health Service in the UK. , 1997, The European respiratory journal.

[14]  L. Hansson,et al.  C‐reactive protein: its role in the diagnosis and follow‐up of infectious diseases , 1997 .

[15]  R. Rodríguez-Roisín,et al.  Community-acquired pneumonia in the elderly: A multivariate analysis of risk and prognostic factors. , 1996, American journal of respiratory and critical care medicine.

[16]  J. Rello,et al.  Severe community-acquired pneumonia in the elderly: epidemiology and prognosis. Study Group for Severe Community-Acquired Pneumonia. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  G. Town,et al.  Community acquired pneumonia: aetiology and usefulness of severity criteria on admission. , 1996, Thorax.

[18]  A. Detsky,et al.  Preferences for home vs hospital care among low-risk patients with community-acquired pneumonia. , 1996, Archives of internal medicine.

[19]  A. Porath,et al.  Appropriateness of hospitalization of patients with community-acquired pneumonia. , 1996, Annals of emergency medicine.

[20]  M. Fine,et al.  Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. , 1996, JAMA.

[21]  B. Lüderitz,et al.  Prognostic analysis and predictive rule for outcome of hospital-treated community-acquired pneumonia. , 1995, The European respiratory journal.

[22]  V L Yu,et al.  Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association. , 1993 .

[23]  V. Yu,et al.  Is pneumonia really the old man's friend? Two-year prognosis after community-acquired pneumonia , 1993, The Lancet.

[24]  S. Soimakallio,et al.  Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland. , 1993, American journal of epidemiology.

[25]  V. Valtonen,et al.  Pneumococcal bacteraemia during a recent decade. , 1992, The Journal of infection.

[26]  M. Fisch,et al.  Predicting death in patients hospitalized for community-acquired pneumonia. , 1991, Annals of internal medicine.

[27]  N. Karalus,et al.  Community acquired pneumonia: aetiology and prognostic index evaluation. , 1991, Thorax.

[28]  D. May,et al.  Surveillance of major causes of hospitalization among the elderly, 1988. , 1991, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

[29]  Community-acquired pneumonia in adults in British hospitals in 1982-1983: a survey of aetiology, mortality, prognostic factors and outcome. The British Thoracic Society and the Public Health Laboratory Service. , 1987, The Quarterly journal of medicine.

[30]  M. Niederman,et al.  Pneumonia in the elderly. , 1986, Clinics in geriatric medicine.

[31]  R. Dixon,et al.  Economic costs of respiratory tract infections in the United States. , 1985, The American journal of medicine.

[32]  J. G. Weg,et al.  Respiratory rate as an indicator of acute respiratory dysfunction. , 1980, JAMA.